View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
DOJ/DEA RIN: 1117-AB17 Publication ID: Spring 2010 
Title: Classification of Three Steroids as Schedule III Anabolic Steroids Under the Controlled Substances Act 
Abstract: This rule classifies the following three steroids as “anabolic steroids” under the Controlled Substances Act (CSA): Boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione. The Drug Enforcement Administration (DEA) believes that this action is necessary in order to prevent the abuse and trafficking of these steroids. 
Agency: Department of Justice(DOJ)  Priority: Other Significant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Completed Actions 
Major: No  Unfunded Mandates: No 
CFR Citation: 21 CFR 1300   
Legal Authority: 21 USC 802    21 USC 871 (b)    21 USC 951    21 USC 958(f)   
Legal Deadline:  None
Timetable:
Action Date FR Cite
NPRM  04/25/2008  73 FR 22294   
NPRM Comment Period End  06/24/2008    
Final Action  12/04/2009  74 FR 63603   
Final Action Effective  01/04/2010    
Additional Information: Docket Number DEA-285
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Small Entities Affected: No  Federalism: No 
Included in the Regulatory Plan: No 
RIN Data Printed in the FR: No 
Agency Contact:
Christine A. Sannerud Ph.D.
Chief, Drug and Chemical Evaluation Section, Office of Diversion Control
Department of Justice
Drug Enforcement Administration
8701 Morrissette Drive,
Washington, DC 20537
Phone:202 307-7183